iPLEDGE program is for:

Rationale

iPLEDGE program is for isotretinoin.

The iPLEDGE program is a risk management strategy designed to prevent fetal exposure to isotretinoin, a medication used to treat severe acne, as it can cause serious birth defects. This program involves strict guidelines for prescribing and obtaining isotretinoin to ensure that patients follow necessary precautions.

A (isotretinoin) CORRECT

Isotretinoin is a powerful retinoid used for severe acne treatment and is known for its potential to cause severe fetal harm if taken during pregnancy. The iPLEDGE program was specifically implemented to monitor and control its distribution, requiring patients to comply with pregnancy prevention measures, thus directly linking the program to isotretinoin.

B (warfarin) YOUR ANSWER

Warfarin is an anticoagulant medication used to prevent blood clots, and while it does require careful management in pregnant patients due to risks of bleeding and fetal complications, it is not associated with the iPLEDGE program. Instead, warfarin has separate guidelines concerning its use in pregnancy.

C (digoxin) YOUR ANSWER

Digoxin is a medication used primarily to treat heart conditions such as atrial fibrillation and heart failure. It is not subject to the iPLEDGE program as it does not have the same teratogenic risks associated with pregnancy as isotretinoin, and its prescription is not monitored by this program.

D (finasteride) YOUR ANSWER

Finasteride is used to treat conditions like benign prostatic hyperplasia and male pattern baldness. While it is contraindicated in pregnancy due to its potential to affect male fetal development, it is not managed under the iPLEDGE program, which is solely related to isotretinoin.

Conclusion

The iPLEDGE program is specifically designed for isotretinoin due to its significant risks during pregnancy. Each of the other medications listed—warfarin, digoxin, and finasteride—has its own safety protocols and considerations regarding pregnancy but is not governed by the iPLEDGE program. Understanding the specific drugs associated with such risk management programs is crucial for safe prescribing practices.

iPLEDGE program is for:

iPLEDGE program is for isotretinoin.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test